New Medicine | East Sunshine "Star Control Pharmaceutical" was sentenced to infringement

On August 4th, Bolinger Yinghan issued a statement through the official WeChat account saying that it received an administrative ruling from the State Intellectual Property Office and determined that Guangdong East Sunshine Pharmaceutical Co., Ltd. and its affiliated parties Yichang Dongguang Yangjiang Pharmaceutical Co., Ltd. violated it. The patent of the hypoglycemic drugs.

Licorine tablets are a hypoglycemic drug independently developed by Bolinger Yingehan. It was approved in China in 2013. It is currently one of the best -selling hypoglycemic drugs in China. above.

In July 2020, East Sunshine won the first imitation of the Lirenine film, and Boliner Yinghan's absolute position in the market was shaken. Bollinger Yinghan said that the East Sunshine Llelene Microex has been hung in a number of provinces across the country and "sold to many customers including hospitals", violating the company's patent rights.

According to the judgment of the State Intellectual Property Office, East Sunshine violated a patent for Boliner Yinghan to protect the Licorine compounds. At present, East Sunshine has been ordered to stop the production and sales of Licorine generic drugs.

Jianxian Bureau learned from Boliner Yinghan: The company's Licheline film is still in the patent protection period of China.

Under the circumstances of clear infringement, East Sunshine's generic drugs may face the risk of delisting. However, in accordance with relevant laws and regulations, East Sunshine can also file an administrative lawsuit against the ruling within a certain period of time, but the ruling is still required during the lawsuit.

According to the CPM new drug research and development monitoring database, in addition to the East Sunshine, the Richelein tablets of Yangtze River, Stone Pharmaceutical, Coron Pharmaceutical and Huahai Pharmaceuticals have been rated.

Writing ｜ Guyue

Edit ｜ Jiang Yun Jia Ting

Operation ｜ Valley

Picture Source | Visual China

####

- END -